Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioxcel Therapeutics Inc.

1.99
+0.03001.53%
Post-market: 1.990.00000.00%16:00 EDT
Volume:263.06K
Turnover:532.74K
Market Cap:12.05M
PE:-0.08
High:2.11
Open:1.99
Low:1.96
Close:1.96
Loading ...
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2022

Major Issues Report

8-K - Current report
Aug 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 23, 2021

Major Issues Report

8-K - Current report
Jul 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 25, 2021

Major Issues Report

8-K - Current report
Jun 22, 2021

Major Issues Report

8-K - Current report
Jun 14, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Mar 15, 2021

Major Issues Report

8-K - Current report
Mar 12, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals